nodes	percent_of_prediction	percent_of_DWPC	metapath
Prochlorperazine—Asthma—Lisinopril—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Prochlorperazine—Influenza—Lisinopril—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Prochlorperazine—Eosinophilia—Lisinopril—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Prochlorperazine—Hypotension—Pentoxifylline—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Prochlorperazine—Cough—Mometasone—systemic scleroderma	0.00249	0.00249	CcSEcCtD
Prochlorperazine—Agranulocytosis—Leflunomide—systemic scleroderma	0.00247	0.00247	CcSEcCtD
Prochlorperazine—Jaundice—Mycophenolic acid—systemic scleroderma	0.00246	0.00246	CcSEcCtD
Prochlorperazine—Urinary retention—Mycophenolate mofetil—systemic scleroderma	0.00246	0.00246	CcSEcCtD
Prochlorperazine—Cardiac arrest—Mycophenolate mofetil—systemic scleroderma	0.00246	0.00246	CcSEcCtD
Prochlorperazine—Insomnia—Pentoxifylline—systemic scleroderma	0.00244	0.00244	CcSEcCtD
Prochlorperazine—Nervousness—Captopril—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Prochlorperazine—Pancytopenia—Lisinopril—systemic scleroderma	0.00242	0.00242	CcSEcCtD
Prochlorperazine—Dyspnoea—Pentoxifylline—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Prochlorperazine—Somnolence—Pentoxifylline—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Prochlorperazine—Apnoea—Methotrexate—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Prochlorperazine—Dry mouth—Mometasone—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Prochlorperazine—Erythema multiforme—Azathioprine—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Prochlorperazine—Vision blurred—Captopril—systemic scleroderma	0.00236	0.00236	CcSEcCtD
Prochlorperazine—Agranulocytosis—Mycophenolic acid—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Lisinopril—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Prochlorperazine—Oedema peripheral—Leflunomide—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Mometasone—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Lisinopril—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Prochlorperazine—Weight increased—Lisinopril—systemic scleroderma	0.00232	0.00232	CcSEcCtD
Prochlorperazine—Infection—Mometasone—systemic scleroderma	0.00231	0.00231	CcSEcCtD
Prochlorperazine—Constipation—Pentoxifylline—systemic scleroderma	0.00231	0.00231	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Lisinopril—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Prochlorperazine—Angioedema—Captopril—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Prochlorperazine—Arrhythmia—Azathioprine—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Prochlorperazine—Erythema multiforme—Leflunomide—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Prochlorperazine—Asthma—Mycophenolate mofetil—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Prochlorperazine—Influenza—Mycophenolate mofetil—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Prochlorperazine—Dysphagia—Mycophenolate mofetil—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Prochlorperazine—Oedema peripheral—Mycophenolic acid—systemic scleroderma	0.00223	0.00223	CcSEcCtD
Prochlorperazine—Jaundice—Lisinopril—systemic scleroderma	0.00221	0.00221	CcSEcCtD
Prochlorperazine—Cough—Captopril—systemic scleroderma	0.00219	0.00219	CcSEcCtD
Prochlorperazine—Urticaria—Pentoxifylline—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Prochlorperazine—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00213	0.00213	CcSEcCtD
Prochlorperazine—Arrhythmia—Leflunomide—systemic scleroderma	0.00212	0.00212	CcSEcCtD
Prochlorperazine—Pancytopenia—Mycophenolate mofetil—systemic scleroderma	0.00212	0.00212	CcSEcCtD
Prochlorperazine—Agranulocytosis—Lisinopril—systemic scleroderma	0.00212	0.00212	CcSEcCtD
Prochlorperazine—Dry mouth—Captopril—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Prochlorperazine—Dyspnoea—Mometasone—systemic scleroderma	0.00208	0.00208	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Mycophenolate mofetil—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Captopril—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Prochlorperazine—Weight increased—Mycophenolate mofetil—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Prochlorperazine—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Prochlorperazine—Pulmonary embolism—Methotrexate—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Mycophenolate mofetil—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Prochlorperazine—Oedema peripheral—Lisinopril—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Captopril—systemic scleroderma	0.002	0.002	CcSEcCtD
Prochlorperazine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Prochlorperazine—Muscle spasms—Leflunomide—systemic scleroderma	0.00199	0.00199	CcSEcCtD
Prochlorperazine—Leukopenia—Azathioprine—systemic scleroderma	0.00196	0.00196	CcSEcCtD
Prochlorperazine—Vision blurred—Leflunomide—systemic scleroderma	0.00195	0.00195	CcSEcCtD
Prochlorperazine—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Prochlorperazine—Erythema multiforme—Lisinopril—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Prochlorperazine—Nervousness—Mycophenolic acid—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Prochlorperazine—Hypotension—Captopril—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Prochlorperazine—Pruritus—Pentoxifylline—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Prochlorperazine—Muscle spasms—Mycophenolic acid—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Prochlorperazine—Aplastic anaemia—Methotrexate—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Prochlorperazine—Angioedema—Leflunomide—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Prochlorperazine—Increased appetite—Prednisone—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Prochlorperazine—Vision blurred—Mycophenolic acid—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Prochlorperazine—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Prochlorperazine—Insomnia—Captopril—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Prochlorperazine—Leukopenia—Leflunomide—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Prochlorperazine—Tremor—Mycophenolic acid—systemic scleroderma	0.00185	0.00185	CcSEcCtD
Prochlorperazine—Coma—Methotrexate—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Prochlorperazine—Body temperature increased—Mometasone—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Prochlorperazine—Dyspnoea—Captopril—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Prochlorperazine—Arrhythmia—Lisinopril—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Prochlorperazine—Somnolence—Captopril—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Prochlorperazine—Agitation—Mycophenolic acid—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Prochlorperazine—Gynaecomastia—Methotrexate—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Prochlorperazine—Cough—Leflunomide—systemic scleroderma	0.0018	0.0018	CcSEcCtD
Prochlorperazine—Dizziness—Pentoxifylline—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Prochlorperazine—Erythema—Lisinopril—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Prochlorperazine—Infection—Azathioprine—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Prochlorperazine—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Prochlorperazine—Oedema peripheral—Mycophenolate mofetil—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Prochlorperazine—Constipation—Captopril—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Azathioprine—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Prochlorperazine—Skin disorder—Azathioprine—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Prochlorperazine—Nervousness—Lisinopril—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Prochlorperazine—Dry mouth—Leflunomide—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Prochlorperazine—Cough—Mycophenolic acid—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Prochlorperazine—Convulsion—Mycophenolic acid—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Prochlorperazine—Muscle spasms—Lisinopril—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Prochlorperazine—Rash—Pentoxifylline—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Prochlorperazine—Dermatitis—Pentoxifylline—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Prochlorperazine—Headache—Pentoxifylline—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Prochlorperazine—Infection—Leflunomide—systemic scleroderma	0.00168	0.00168	CcSEcCtD
Prochlorperazine—Vision blurred—Lisinopril—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Prochlorperazine—Hypotension—Azathioprine—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Prochlorperazine—Photosensitivity—Methotrexate—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Prochlorperazine—Cardiac arrest—Prednisone—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Prochlorperazine—Tremor—Lisinopril—systemic scleroderma	0.00166	0.00166	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Leflunomide—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Prochlorperazine—Pruritus—Mometasone—systemic scleroderma	0.00165	0.00165	CcSEcCtD
Prochlorperazine—Dry mouth—Mycophenolic acid—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Prochlorperazine—Skin disorder—Leflunomide—systemic scleroderma	0.00164	0.00164	CcSEcCtD
Prochlorperazine—Angioedema—Lisinopril—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Prochlorperazine—Body temperature increased—Captopril—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Prochlorperazine—Oedema—Mycophenolic acid—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Prochlorperazine—Infection—Mycophenolic acid—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Prochlorperazine—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.0016	0.0016	CcSEcCtD
Prochlorperazine—Leukopenia—Lisinopril—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Prochlorperazine—Hypotension—Leflunomide—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Prochlorperazine—Skin disorder—Mycophenolic acid—systemic scleroderma	0.00156	0.00156	CcSEcCtD
Prochlorperazine—Dermatitis exfoliative—Methotrexate—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Prochlorperazine—Cough—Lisinopril—systemic scleroderma	0.00155	0.00155	CcSEcCtD
Prochlorperazine—Insomnia—Leflunomide—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Prochlorperazine—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Prochlorperazine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Prochlorperazine—Dyspnoea—Leflunomide—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Prochlorperazine—Hypotension—Mycophenolic acid—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Prochlorperazine—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Prochlorperazine—Dry mouth—Lisinopril—systemic scleroderma	0.00148	0.00148	CcSEcCtD
Prochlorperazine—Rash—Mometasone—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Prochlorperazine—Dermatitis—Mometasone—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Prochlorperazine—Headache—Mometasone—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Prochlorperazine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Prochlorperazine—Insomnia—Mycophenolic acid—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Prochlorperazine—Oedema—Lisinopril—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Prochlorperazine—Pruritus—Captopril—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Prochlorperazine—Constipation—Leflunomide—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Prochlorperazine—Infection—Lisinopril—systemic scleroderma	0.00144	0.00144	CcSEcCtD
Prochlorperazine—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Prochlorperazine—Somnolence—Mycophenolic acid—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Prochlorperazine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Prochlorperazine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Prochlorperazine—Body temperature increased—Azathioprine—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Prochlorperazine—Skin disorder—Lisinopril—systemic scleroderma	0.00141	0.00141	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Prednisone—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Prochlorperazine—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00139	0.00139	CcSEcCtD
Prochlorperazine—Weight increased—Prednisone—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Prochlorperazine—Constipation—Mycophenolic acid—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Prochlorperazine—Hyperglycaemia—Prednisone—systemic scleroderma	0.00137	0.00137	CcSEcCtD
Prochlorperazine—Cough—Mycophenolate mofetil—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Prochlorperazine—Hypotension—Lisinopril—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Prochlorperazine—Dizziness—Captopril—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Prochlorperazine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00135	0.00135	CcSEcCtD
Prochlorperazine—Urticaria—Leflunomide—systemic scleroderma	0.00134	0.00134	CcSEcCtD
Prochlorperazine—Body temperature increased—Leflunomide—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Prochlorperazine—Hypersensitivity—Azathioprine—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Prochlorperazine—Insomnia—Lisinopril—systemic scleroderma	0.00131	0.00131	CcSEcCtD
Prochlorperazine—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Prochlorperazine—Dyspnoea—Lisinopril—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Prochlorperazine—Rash—Captopril—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Prochlorperazine—Dermatitis—Captopril—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Prochlorperazine—Somnolence—Lisinopril—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Prochlorperazine—Headache—Captopril—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Prochlorperazine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Prochlorperazine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Prochlorperazine—Asthma—Methotrexate—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Prochlorperazine—Infection—Mycophenolate mofetil—systemic scleroderma	0.00126	0.00126	CcSEcCtD
Prochlorperazine—Eosinophilia—Methotrexate—systemic scleroderma	0.00125	0.00125	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Prochlorperazine—Hypersensitivity—Leflunomide—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Prochlorperazine—Constipation—Lisinopril—systemic scleroderma	0.00124	0.00124	CcSEcCtD
Prochlorperazine—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Prochlorperazine—Pancytopenia—Methotrexate—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Prochlorperazine—Pruritus—Leflunomide—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Prochlorperazine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Prochlorperazine—Dizziness—Azathioprine—systemic scleroderma	0.00118	0.00118	CcSEcCtD
Prochlorperazine—Erectile dysfunction—Methotrexate—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Prochlorperazine—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Prochlorperazine—Urticaria—Lisinopril—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Prochlorperazine—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Prochlorperazine—Body temperature increased—Lisinopril—systemic scleroderma	0.00115	0.00115	CcSEcCtD
Prochlorperazine—Pruritus—Mycophenolic acid—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Prochlorperazine—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Prochlorperazine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Prochlorperazine—Drowsiness—Methotrexate—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Prochlorperazine—Rash—Azathioprine—systemic scleroderma	0.00113	0.00113	CcSEcCtD
Prochlorperazine—Dermatitis—Azathioprine—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Prochlorperazine—Headache—Azathioprine—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Prochlorperazine—Dizziness—Leflunomide—systemic scleroderma	0.00112	0.00112	CcSEcCtD
Prochlorperazine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00109	0.00109	CcSEcCtD
Prochlorperazine—Arrhythmia—Prednisone—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Prochlorperazine—Hypersensitivity—Lisinopril—systemic scleroderma	0.00107	0.00107	CcSEcCtD
Prochlorperazine—Dizziness—Mycophenolic acid—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Prochlorperazine—Rash—Leflunomide—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Prochlorperazine—Dermatitis—Leflunomide—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Prochlorperazine—Headache—Leflunomide—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Prochlorperazine—Erythema—Prednisone—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Prochlorperazine—Agranulocytosis—Methotrexate—systemic scleroderma	0.00105	0.00105	CcSEcCtD
Prochlorperazine—Pruritus—Lisinopril—systemic scleroderma	0.00103	0.00103	CcSEcCtD
Prochlorperazine—Rash—Mycophenolic acid—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Prochlorperazine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Prochlorperazine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Prochlorperazine—Headache—Mycophenolic acid—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Prochlorperazine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.001	0.001	CcSEcCtD
Prochlorperazine—Vision blurred—Prednisone—systemic scleroderma	0.000994	0.000994	CcSEcCtD
Prochlorperazine—Agitation—Prednisone—systemic scleroderma	0.000969	0.000969	CcSEcCtD
Prochlorperazine—Angioedema—Prednisone—systemic scleroderma	0.000963	0.000963	CcSEcCtD
Prochlorperazine—Dizziness—Lisinopril—systemic scleroderma	0.000958	0.000958	CcSEcCtD
Prochlorperazine—Erythema multiforme—Methotrexate—systemic scleroderma	0.000957	0.000957	CcSEcCtD
Prochlorperazine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000935	0.000935	CcSEcCtD
Prochlorperazine—Rash—Lisinopril—systemic scleroderma	0.000914	0.000914	CcSEcCtD
Prochlorperazine—Convulsion—Prednisone—systemic scleroderma	0.000914	0.000914	CcSEcCtD
Prochlorperazine—Dermatitis—Lisinopril—systemic scleroderma	0.000913	0.000913	CcSEcCtD
Prochlorperazine—Headache—Lisinopril—systemic scleroderma	0.000908	0.000908	CcSEcCtD
Prochlorperazine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000898	0.000898	CcSEcCtD
Prochlorperazine—Erythema—Methotrexate—systemic scleroderma	0.000881	0.000881	CcSEcCtD
Prochlorperazine—Oedema—Prednisone—systemic scleroderma	0.000861	0.000861	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000861	0.000861	CcSEcCtD
Prochlorperazine—Infection—Prednisone—systemic scleroderma	0.000855	0.000855	CcSEcCtD
Prochlorperazine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000839	0.000839	CcSEcCtD
Prochlorperazine—Skin disorder—Prednisone—systemic scleroderma	0.000836	0.000836	CcSEcCtD
Prochlorperazine—Vision blurred—Methotrexate—systemic scleroderma	0.00083	0.00083	CcSEcCtD
Prochlorperazine—Rash—Mycophenolate mofetil—systemic scleroderma	0.0008	0.0008	CcSEcCtD
Prochlorperazine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.0008	0.0008	CcSEcCtD
Prochlorperazine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000795	0.000795	CcSEcCtD
Prochlorperazine—Leukopenia—Methotrexate—systemic scleroderma	0.000789	0.000789	CcSEcCtD
Prochlorperazine—Insomnia—Prednisone—systemic scleroderma	0.000778	0.000778	CcSEcCtD
Prochlorperazine—Cough—Methotrexate—systemic scleroderma	0.000769	0.000769	CcSEcCtD
Prochlorperazine—Convulsion—Methotrexate—systemic scleroderma	0.000763	0.000763	CcSEcCtD
Prochlorperazine—Constipation—Prednisone—systemic scleroderma	0.000736	0.000736	CcSEcCtD
Prochlorperazine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000719	0.000719	CcSEcCtD
Prochlorperazine—Infection—Methotrexate—systemic scleroderma	0.000714	0.000714	CcSEcCtD
Prochlorperazine—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000704	0.000704	CcSEcCtD
Prochlorperazine—Skin disorder—Methotrexate—systemic scleroderma	0.000699	0.000699	CcSEcCtD
Prochlorperazine—Urticaria—Prednisone—systemic scleroderma	0.000684	0.000684	CcSEcCtD
Prochlorperazine—Body temperature increased—Prednisone—systemic scleroderma	0.00068	0.00068	CcSEcCtD
Prochlorperazine—Hypotension—Methotrexate—systemic scleroderma	0.000672	0.000672	CcSEcCtD
Prochlorperazine—Insomnia—Methotrexate—systemic scleroderma	0.00065	0.00065	CcSEcCtD
Prochlorperazine—Dyspnoea—Methotrexate—systemic scleroderma	0.000641	0.000641	CcSEcCtD
Prochlorperazine—Somnolence—Methotrexate—systemic scleroderma	0.000639	0.000639	CcSEcCtD
Prochlorperazine—Hypersensitivity—Prednisone—systemic scleroderma	0.000634	0.000634	CcSEcCtD
Prochlorperazine—Pruritus—Prednisone—systemic scleroderma	0.000609	0.000609	CcSEcCtD
Prochlorperazine—Urticaria—Methotrexate—systemic scleroderma	0.000571	0.000571	CcSEcCtD
Prochlorperazine—Dizziness—Prednisone—systemic scleroderma	0.000569	0.000569	CcSEcCtD
Prochlorperazine—Body temperature increased—Methotrexate—systemic scleroderma	0.000569	0.000569	CcSEcCtD
Prochlorperazine—Rash—Prednisone—systemic scleroderma	0.000543	0.000543	CcSEcCtD
Prochlorperazine—Dermatitis—Prednisone—systemic scleroderma	0.000542	0.000542	CcSEcCtD
Prochlorperazine—Headache—Prednisone—systemic scleroderma	0.000539	0.000539	CcSEcCtD
Prochlorperazine—Hypersensitivity—Methotrexate—systemic scleroderma	0.00053	0.00053	CcSEcCtD
Prochlorperazine—Pruritus—Methotrexate—systemic scleroderma	0.000509	0.000509	CcSEcCtD
Prochlorperazine—Dizziness—Methotrexate—systemic scleroderma	0.000476	0.000476	CcSEcCtD
Prochlorperazine—Rash—Methotrexate—systemic scleroderma	0.000453	0.000453	CcSEcCtD
Prochlorperazine—Dermatitis—Methotrexate—systemic scleroderma	0.000453	0.000453	CcSEcCtD
Prochlorperazine—Headache—Methotrexate—systemic scleroderma	0.000451	0.000451	CcSEcCtD
